51 |
WARNER CHILCOTT LABORATORIES IRELAND LIMITED et al v. MYLAN PHARMACEUTICALS INC. et al |
2:09-cv-02073 |
D.N.J. |
|
|
|
|
52 |
WARNER CHILCOTT LABORATORIES IRELAND LIMITED et al v. MYLAN PHARMACEUTICALS INC. et al |
2:09-cv-02073 |
D.N.J. |
|
|
|
|
53 |
WARNER CHILCOTT LABORATORIES IRELAND LIMITED et al v. MYLAN PHARMACEUTICALS INC. et al |
2:09-cv-02073 |
D.N.J. |
|
|
|
|
54 |
NOVO NORDISK INC. et al v. MYLAN PHARMACEUTICALS INC. |
3:09-cv-02445 |
D.N.J. |
|
|
|
|
55 |
NOVO NORDISK INC. et al v. MYLAN PHARMACEUTICALS INC. |
3:09-cv-02445 |
D.N.J. |
|
|
|
|
56 |
Warner Chilcott Company, LLC et al v. Mylan Pharmaceuticals Inc. |
1:10-cv-00059 |
N.D.W.Va. |
|
|
|
|
57 |
Warner Chilcott Company, LLC et al v. Mylan Pharmaceuticals Inc. |
1:10-cv-00059 |
N.D.W.Va. |
|
|
|
|
58 |
Pfizer Inc. et al v. Mylan Inc. et al |
1:10-cv-00528 |
D.Del. |
|
|
|
|
59 |
Pfizer Inc. et al v. Mylan Inc. et al |
1:10-cv-00528 |
D.Del. |
|
|
|
|
60 |
Pfizer Inc. et al v. Mylan Inc. et al |
1:10-cv-00528 |
D.Del. |
|
|
|
|
61 |
Pfizer Inc. et al v. Mylan Inc. et al |
1:10-cv-00528 |
D.Del. |
|
|
|
|
62 |
Pfizer Inc. et al v. Mylan Inc. et al |
1:10-cv-00528 |
D.Del. |
|
|
|
|
63 |
Pfizer Inc. et al v. Mylan Inc. et al |
1:10-cv-00528 |
D.Del. |
|
|
|
|
64 |
Pfizer Inc. et al v. Mylan Inc. et al |
1:10-cv-00528 |
D.Del. |
|
|
|
|
65 |
Abbott Laboratories et al v. Mylan Inc. et al |
1:10-cv-00559 |
D.Del. |
|
|
|
|
66 |
Abbott Laboratories et al v. Mylan Inc. et al |
1:10-cv-00559 |
D.Del. |
|
|
|
|
67 |
Astrazeneca Pharmaceuticals LP et al v. Mylan Pharmaceuticals Inc. et al |
1:10-cv-00199 |
N.D.W.Va. |
|
|
|
|
68 |
Astrazeneca Pharmaceuticals LP et al v. Mylan Pharmaceuticals Inc. et al |
1:10-cv-00199 |
N.D.W.Va. |
|
|
|
|
69 |
Somaxon Pharmaceuticals Inc. et al v. Actavis Elizabeth LLC et al |
1:10-cv-01100 |
D.Del. |
|
|
|
|
70 |
Somaxon Pharmaceuticals Inc. et al v. Actavis Elizabeth LLC et al |
1:10-cv-01100 |
D.Del. |
|
|
|
|
71 |
Novartis Pharmaceuticals Corporation et al v. Mylan Pharmaceuticals Inc. et al |
1:11-cv-00015 |
N.D.W.Va. |
|
|
|
|
72 |
Novartis Pharmaceuticals Corporation et al v. Mylan Pharmaceuticals Inc. et al |
1:11-cv-00015 |
N.D.W.Va. |
|
|
|
|
73 |
Vivelle Ventures LLC et al v. Mylan Technologies, Inc. et al |
1:11-cv-01187 |
S.D.N.Y. |
|
|
|
|
74 |
Vivelle Ventures LLC et al v. Mylan Technologies, Inc. et al |
1:11-cv-01187 |
S.D.N.Y. |
|
|
|
|
75 |
Vivelle Ventures LLC et al v. Mylan Technologies, Inc. et al |
1:11-cv-01187 |
S.D.N.Y. |
|
|
|
|
76 |
Endo Pharmaceuticals Inc. v. Mylan Technologies Inc. et al |
1:11-cv-00220 |
D.Del. |
|
|
|
|
77 |
Pfizer Inc. v. Mylan Pharmaceuticals Inc. et al |
1:11-cv-00269 |
D.Del. |
|
|
|
|
78 |
Bayer Schering Pharma AG et al v. Mylan Pharmaceuticals Inc. et al |
2:11-cv-00604 |
D.Nev. |
|
|
|
|
79 |
Bayer Schering Pharma AG et al v. Mylan Pharmaceuticals Inc. et al |
2:11-cv-00604 |
D.Nev. |
|
|
|
|
80 |
DTECH Communications, LLC v. OSC Engineering, Inc. et al |
3:11-cv-01425 |
S.D.Cal. |
|
|
|
|
81 |
DTECH Communications, LLC v. OSC Engineering, Inc. et al |
3:11-cv-01425 |
S.D.Cal. |
|
|
|
|
82 |
OREXO AB v. MYLAN PHARMACEUTICALS INC. et al |
3:11-cv-03788 |
D.N.J. |
|
|
|
|
83 |
ABBOTT LABORATORIES et al v. MYLAN PHARMACEUTICALS INC. et al |
2:11-cv-04966 |
D.N.J. |
|
|
|
|
84 |
ABBOTT LABORATORIES et al v. MYLAN PHARMACEUTICALS INC. et al |
2:11-cv-04966 |
D.N.J. |
|
|
|
|
85 |
TAKEDA PHARMACEUTICAL COMPANY LIMITED et al v. MYLAN, INC. et al |
2:12-cv-00026 |
W.D.Pa. |
|
|
|
|
86 |
TAKEDA PHARMACEUTICAL COMPANY LIMITED et al v. MYLAN, INC. et al |
2:12-cv-00026 |
W.D.Pa. |
|
|
|
|
87 |
TAKEDA PHARMACEUTICAL COMPANY LIMITED et al v. MYLAN, INC. et al |
2:12-cv-00026 |
W.D.Pa. |
|
|
|
|
88 |
TAKEDA PHARMACEUTICAL COMPANY LIMITED et al v. MYLAN, INC. et al |
2:12-cv-00026 |
W.D.Pa. |
|
|
|
|
89 |
TAKEDA PHARMACEUTICAL COMPANY LIMITED et al v. MYLAN, INC. et al |
2:12-cv-00026 |
W.D.Pa. |
|
|
|
|
90 |
SHIRE LLC et al v. MYLAN PHARMACEUTICALS, INC. et al |
2:12-cv-00638 |
D.N.J. |
|
|
|
|
91 |
SHIRE LLC et al v. MYLAN PHARMACEUTICALS, INC. et al |
2:12-cv-00638 |
D.N.J. |
|
|
|
|
92 |
SHIRE LLC et al v. MYLAN PHARMACEUTICALS, INC. et al |
2:12-cv-00638 |
D.N.J. |
|
|
|
|
93 |
SHIRE LLC et al v. MYLAN PHARMACEUTICALS, INC. et al |
2:12-cv-00638 |
D.N.J. |
|
|
|
|
94 |
Takeda Pharmaceutical Company Limited et al v. Mylan, Inc. et al |
1:12-cv-02038 |
S.D.N.Y. |
|
|
|
|
95 |
Takeda Pharmaceutical Company Limited et al v. Mylan, Inc. et al |
1:12-cv-02038 |
S.D.N.Y. |
|
|
|
|
96 |
Takeda Pharmaceutical Company Limited et al v. Mylan, Inc. et al |
1:12-cv-02038 |
S.D.N.Y. |
|
|
|
|
97 |
Takeda Pharmaceutical Company Limited et al v. Mylan, Inc. et al |
1:12-cv-02038 |
S.D.N.Y. |
|
|
|
|
98 |
Takeda Pharmaceutical Company Limited et al v. Mylan, Inc. et al |
1:12-cv-02038 |
S.D.N.Y. |
|
|
|
|
99 |
Teva Pharmaceuticals USA, Inc. et al v. Synthon Pharmaceuticals, Inc. et al |
1:12-cv-02556 |
S.D.N.Y. |
|
- 2 University heritage or tie
- 8 Product company
|
|
|
100 |
Teva Pharmaceuticals USA, Inc. et al v. Synthon Pharmaceuticals, Inc. et al |
1:12-cv-02556 |
S.D.N.Y. |
|
- 2 University heritage or tie
- 8 Product company
|
|
|